Cite
HARVARD Citation
Rinaldi, F. et al. (2018). Evidence of B-cell dysregulation in severe CNS inflammation after alemtuzumab therapy. Neurology. 5 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rinaldi, F. et al. (2018). Evidence of B-cell dysregulation in severe CNS inflammation after alemtuzumab therapy. Neurology. 5 (1), p. . [Online].